The FDA authorized four menthol e-cigarettes from Njoy, highlighting the potential benefits of vaping in reducing the toll of smoking-related diseases such as cancer, lung disease, and heart disease.
Parents and anti-tobacco groups criticized the decision, expressing concerns about the perpetuation of youth vaping and the creation of future lifetime customers among children by the vaping industry.
Despite the decline in youth vaping rates, the FDA's approval of menthol e-cigarettes raises concerns about the appeal of flavored vaping products, specifically among adolescents, as evidenced by their high usage of flavored e-cigarettes.
Njoy, acquired by Altria, stands out as one of the few companies with FDA approval for vaping products, with its menthol e-cigarettes available in cartridge and disposable form, targeting adult smokers seeking alternatives to traditional tobacco.
Collection
[
|
...
]